Does atorvastatin therapy change the anti‐Xa activity in xabans‐treated patients with atrial fibrillation?

Atorvastatin and direct oral factor Xa inhibitors (xabans) are frequently co‐administrated in patients with atrial fibrillation (AF). However, no studies investigating the possibility of the pharmacologic interaction between these agents have been conducted. The aim of this prospective observational...

Descripción completa

Detalles Bibliográficos
Autores principales: Škorňová, Ingrid, Samoš, Matej, Bolek, Tomáš, Stančiaková, Lucia, Vádelová, Ľubica, Galajda, Peter, Staško, Ján, Kubisz, Peter, Mokáň, Marián
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8118196/
https://www.ncbi.nlm.nih.gov/pubmed/33984191
http://dx.doi.org/10.1002/prp2.730

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8118196/
https://www.ncbi.nlm.nih.gov/pubmed/33984191
http://dx.doi.org/10.1002/prp2.730

Ejemplares similares